Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Ponders Devoting Sequencing Capacity to Genetic Diseases; Invites Researchers to Comment

NEW YORK, Aug 8 (GenomeWeb News) - The National Human Genome Research Institute is considering turning its sequencing capacity into a mechanism that could pinpoint genetic variations that cause human Mendelian disorders, and is trying to gauge interest for such a program.


Last week, the institute invited scientists involved in this kind of research to say whether sequencing services provided by a large-scale center would benefit them. "The NHGRI is particularly interested in cases in which a major roadblock to completing those projects could be overcome by large-scale sequencing, and where the amount of sequencing required would be prohibitive to the individual investigator," NIGRI said.


For instance, appropriate cases could be those in which a disorder has been mapped to an interval that is too large for an individual to sequence, or where the sequencing of candidate genes has not yielded success, suggesting that the relevant change resides in a noncoding region.


For more information, click here.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more